1.90 - 2.15
0.48 - 2.54
9.88M / 2.92M (Avg.)
-0.48 | -4.19
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
41.81%
EBIT growth 50-75% of ACB.TO's 62.99%. Martin Whitman would suspect suboptimal resource allocation.
41.81%
Operating income growth at 50-75% of ACB.TO's 61.45%. Martin Whitman would doubt the firm’s ability to compete efficiently.
45.90%
Net income growth at 50-75% of ACB.TO's 62.30%. Martin Whitman would question fundamental disadvantages in expenses or demand.
47.62%
EPS growth at 75-90% of ACB.TO's 62.36%. Bill Ackman would push for improved profitability or share repurchases to catch up.
47.62%
Diluted EPS growth at 75-90% of ACB.TO's 62.36%. Bill Ackman would expect further improvements in net income or share count reduction.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-4156.92%
Negative OCF growth while ACB.TO is at 46.18%. Joel Greenblatt would demand a turnaround plan focusing on real cash generation.
-4156.92%
Negative FCF growth while ACB.TO is at 46.18%. Joel Greenblatt would demand improved cost control or more strategic capex discipline.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-103.85%
Both show negative 10Y OCF/share CAGR. Martin Whitman would question if the entire market or product set is shrinking or too capital-intensive.
-103.85%
Both show negative mid-term OCF/share growth. Martin Whitman might suspect a challenged environment or large capital demands for both.
-103.85%
Negative 3Y OCF/share CAGR while ACB.TO stands at 12.72%. Joel Greenblatt would demand an urgent turnaround in the firm’s cost or revenue drivers.
83.46%
Positive 10Y CAGR while ACB.TO is negative. John Neff might see a substantial advantage in bottom-line trajectory.
83.46%
5Y net income/share CAGR above 1.5x ACB.TO's 53.11%. David Dodd would confirm if the firm’s strategy is more effective in generating mid-term profits.
83.46%
Positive short-term CAGR while ACB.TO is negative. John Neff would see a clear advantage in near-term profit trajectory.
-57.10%
Both are negative. Martin Whitman suspects the segment is in decline or saddled with persistent unprofitability or write-downs.
-57.10%
Both show negative equity/share growth mid-term. Martin Whitman suspects cyclical or structural challenges for each company.
-57.10%
Both show negative short-term equity/share CAGR. Martin Whitman suspects an industry slump or unprofitable expansions for both players.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
56.34%
Our AR growth while ACB.TO is cutting. John Neff questions if the competitor outperforms in collections or if we’re pushing credit to maintain sales.
No Data
No Data available this quarter, please select a different quarter.
-3.01%
Both reduce assets yoy. Martin Whitman suspects a broader sector retraction or post-boom asset trimming cycle.
-2.09%
Both erode book value/share. Martin Whitman suspects a difficult environment or poor capital deployment for both players.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-41.81%
Both reduce SG&A yoy. Martin Whitman sees a cost war or cyclical slowdown forcing overhead cuts.